The use of topical ketorolac 0.5% for pain relief following cyclophotocoagulation

Ophthalmic Surgery Lasers and Imaging

Volumn 34, Issue 5, 2003, Pages 381-385

  Birt, Catherine M ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b Department of Ophthalmology ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC TROMETAMOL;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; GLAUCOMA; HUMAN; LASER COAGULATION; PAIN ASSESSMENT; PALLIATIVE THERAPY; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CILIARY BODY; DRUG THERAPY, COMBINATION; FEMALE; GLAUCOMA; HUMANS; KETOROLAC; LASER COAGULATION; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PREDNISOLONE; PROSPECTIVE STUDIES; SAFETY; TREATMENT OUTCOME;

EID: 0042915807     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Krupin T, Mitchell KB, Becker B. Cyclocryotherapy in neovascular glaucoma. Am J Ophthalmol. 1978;86:24-26.
2. Pinkerton RM. The mechanism of symptomatic relief in cyclocryotherapy. Can J Ophthalmol. 1973;8:408-412.
3. Prost M. Cyclocryotherapy for glaucoma: evaluation of techniques. Surv Ophthalmol. 1983;28:93-100.
4. Walton DS, Grant WM. Penetrating cyclodiathermy for filtration. Arch Ophthalmol. 1970;83:47-48.
5. Stocker FW. Technique of semipenetrating cyclodiathermy puncture. Arch Ophthalmol. 1965;74:813-814.
6. Beiran I, Rootman DS, Trope GE, Buys YM. Long-term results of transscleral Nd:YAG cyclophotocoagulation for refractory glaucoma postpenetrating keratoplasty. J Glaucoma. 2000;9:268-272.
7. al-Ghamdi S, al-Obeidan S, Tomey KF, al-Jadaan I. Transscleral neodymium:YAG laser cyclophotocoagulation for end-stage glaucoma, refractory glaucoma, and painful blind eyes. Ophthalmic Surg. 1993;24:526-529.
8. Kalenak JW, Parkinson JM, Kass MA, Kolker AE. Transscleral neodymium:YAG laser cyclocoagulation for uncontrolled glaucoma. Ophthalmic Surg. 1990; 21:346-351.
9. Schlote T, Derse M, Rassmann K, Nicaeus T, Dietz K, Thiel HJ. Efficacy and safety of contact transscleral diode laser cyclophotocoagulation for advanced glaucoma. J Glaucoma. 2001;10:294-301.
10. Mistlberger A, Liebmann JM, Tschiderer H, Ritch R, Ruckhofer J, Grabner G. Diode laser transscleral cyclophotocoagulation for refractory glaucoma. J Glaucoma. 2001;10:288-293.
11. Threlkeld AB, Johnson MH. Contact transscleral diode cyclophotocoagulation for refractory glaucoma. J Glaucoma. 1999;8:3-7.
12. Yap-Veloso MI, Simmons RB, Echelman DA, Gonzales TK, Veira WJ, Simmons RJ. Intraocular pressure control after contact transscleral diode cyclophotocoagulation in eyes with intractable glaucoma. J Glaucoma. 1998;7:319-328.
13. Schuman JS, Puliafito CA, Allingham RR, et al. Contact transscleral continuous wave neodymium: YAG laser cyclophotocoagulation. Ophthalmology. 1990;97:571-580.
14. Youn J, Cox TA, Herndon LW, Allingham RR, Shields MB. A clinical comparison of transscleral cyclophotocoagulation with neodymium:YAG and semiconductor diode lasers. Am J Ophthalmol. 1998; 126:640-647.
15. Ulbig MW, McHugh DA, McNaught AI, Hamilton AM. Clinical comparison of semiconductor diode versus neodymium:YAG non-contact cyclophotocoagulation. Br J Ophthalmol. 1995;79:569-574.
16. Pastor SA, Singh K, Lee DA, et al. Cyclophotocoagulation: a report by the American Academy of Ophthalmology. Ophthalmology. 2001;108:2130-2138.
17. Suzuki Y, Araie M, Yumita A, Yamamoto T. Transscleral Nd:YAG laser cyclophotocoagulation versus cyclocryotherapy. Graefes Arch Clin Exp Ophthalmol. 1991; 229:33-36.
18. Schuman JS, Bellows AR, Shingleton BJ, et al. Contact transscleral Nd: YAG laser cyclophotocoagulation: midterm results. Ophthalmology. 1992;99:1089-1094.
19. Solomon KD, Cheetham JK, DeGryse R, Brint SF, Rosenthal A. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology. 2001;108:331-337.
20. Rajpal RK, Cooperman BB. Analgesic efficacy and safety of ketorolac after photorefractive keratectomy: Ketorolac Study Group. J Refract Surg. 1999;15:661-667.
21. Arshinoff S, D'Addario D, Sadler C, Bilotta R, Johnson TM. Use of topical nonsteroidal anti-inflammatory drugs in excimer laser photorefractive keratectomy. J Cataract Refract Surg. 1994;20(suppl):216-222.